Mark Cragg
7Patents
1h-index
13Co-inventors
44Inventor score
Filing activity: Aug 19, 2011 → Apr 20, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11001638B2 | Immunomodulatory antibodies | Chemistry; Metallurgy | 1 | Active |
| US10525129B2 | Combined use of Fc gamma RIIb (CD32B) and CD20-specific antibodies | Human Necessities | 1 | Active |
| US12371498B2 | Combination and use of antibodies | Chemistry; Metallurgy | 0 | Active |
| US12344673B2 | Medicaments, uses and methods | Chemistry; Metallurgy | 0 | Active |
| US11780929B2 | Immunomodulatory antibodies | Chemistry; Metallurgy | 0 | Active |
| US11623005B2 | Combined use of FcγRIIb (CD32B) and CD20 specific antibodies | Human Necessities | 0 | Active |
| US12325754B2 | Cancer and B-cell related disease therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.